 | | | | Novavax Inc on Monday revealed a sharp drop in its COVID-19 research funding for the first quarter and said it shipped less than a fourth of the total planned COVID vaccine deliveries for 2022. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | China's two largest cities tightened COVID-19 curbs on Monday, fuelling public angst and even questions about the legality of its uncompromising battle with the virus that has battered the world's second largest economy. | | | | | | France will lift most restrictions on poultry farming that had been imposed country-wide to contain the fast spread of bird flu after a decrease in the number of outbreaks in recent weeks, the agriculture ministry said on Monday. | | | | | | Italy will launch a cull of wild boars around Rome after African swine fever was found in one of the thousands that live in the Italian capital and the surrounding countryside, local authorities said on Monday. | | | | | | The World Health Organization (WHO) and its COVID-19 vaccine partner Gavi have no immediate plans to buy shots made by Aspen Pharmacare , the two bodies said, dealing a blow to Africa's efforts to develop its own vaccine production capacity. | | | | | | Mexican President Andres Manuel Lopez Obrador on Monday lavished praise on Cuba's leader, reiterated his wish for the Caribbean island nation to be invited to the Summit of the Americas in June and said Mexico would be hiring over 500 Cuban doctors. | | | | | | China's two largest cities tightened COVID-19 curbs on Monday, fuelling public angst and even questions about the legality of its uncompromising battle with the virus that has battered the world's second largest economy. | | | | | | The technical body of Brazilian antitrust watchdog Cade has recommended the approval of the acquisition of pharmacy chain Extrafarma by rival Pague Menos, the company said on Monday. | | | | | | BioNTech's first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer , but the German biotech firm is still forecasting a full-year decline in vaccine sales. | | | | | |
